M. Freund
Impact in
- Hematology top 2%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Genetics top 5%
- Mesenchymal stem cell research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 25
- Chronic Myeloid Leukemia Treatments 11
- Acute Myeloid Leukemia Research 10
- Hematopoietic Stem Cell Transplantation 5
- Erythropoietin and Anemia Treatment 3
- Genetics 14
- Chronic Lymphocytic Leukemia Research 10
- Co-authors
- J. P. KaltwasserP. MeusersHubert SchrezenmeierAruna RaghavacharNorbert FrickhofenF. HerrmannHans‐Georg VogtH. Heimpel
- Journals
- Blood (2 papers)Journal of Molecular Medicine (2 papers)Annals of Hematology (2 papers)Journal of Clinical Oncology (2 papers)Journal of Biological Chemistry (2 papers)
- Partner nations
- GermanySwitzerlandFrance
In The Last Decade
M. Freund
43 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 70
- Hematology 532
- Genetics 294
- Oncology 288
- Pathology and Forensic Medicine 173
- Immunology 187
Countries citing papers authored by M. Freund
This map shows the geographic impact of M. Freund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Freund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Freund more than expected).
Fields of papers citing papers by M. Freund
This network shows the impact of papers produced by M. Freund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Freund. The network helps show where M. Freund may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Freund, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 2 | |
| 2 | 2005 | 23 | |
| 3 | 2004 | 2 | |
| 4 | 2004 | 5 | |
| 5 | 2002 | 2 | |
| 6 | 2002 | 5 | |
| 7 | 1998 | 83 | |
| 8 | 1995 | 7 | |
| 9 | A new fibroblast growth stimulating activity from the human megakaryoblastic leukaemia cell line ELF-153: in vitro and in vivo findings. | 1995 | 3 |
| 10 | 1994 | 34 | |
| 11 | 1992 | 5 | |
| 12 | 1992 | 2 | |
| 13 | 1991 | 38 | |
| 14 | 1990 | 4 | |
| 15 | 1990 | 10 | |
| 16 | 1990 | 9 | |
| 17 | Detection of cells with multidrug-resistant phenotype in myeloproliferative disorders before therapy. | 1989 | 11 |
| 18 | 1988 | 11 | |
| 19 | 1988 | 1 | |
| 20 | 1987 | 0 |
About M. Freund
M. Freund is a scholar working on Hematology, Genetics, Transplantation, Immunology and Emergency Medicine, having authored 47 papers that have together received 1.1k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (11 papers), Chronic Lymphocytic Leukemia Research (10 papers), Acute Myeloid Leukemia Research (10 papers), Acute Lymphoblastic Leukemia research (8 papers), Hematopoietic Stem Cell Transplantation (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Erythropoietin and Anemia Treatment (3 papers) and Hematological disorders and diagnostics (3 papers). The work is most often cited by research in Hematology (532 citations), Genetics (294 citations), Oncology (288 citations), Pathology and Forensic Medicine (173 citations) and Immunology (187 citations). M. Freund has collaborated with scholars based in Germany, Switzerland and France. Frequent co-authors include J. P. Kaltwasser, P. Meusers, Hubert Schrezenmeier, Aruna Raghavachar, Norbert Frickhofen, F. Herrmann, Hans‐Georg Vogt, H. Heimpel, A Salama and Ursula Günthert. Their work appears in journals such as Blood, Journal of Molecular Medicine, Annals of Hematology, Journal of Clinical Oncology and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.